Cancer Management & Treatment | Cancer Research & Drug Trials
Cancer Therapy Advisor offers the latest cancer management and treatment info, cancer research news, and more for oncologists and medical professionals.
Cancer Management - Cancer Therapy Advisor
Cancer Therapy Advisor’s cancer treatment resources now include the most recent guideline-based information to inform oncologists and oncology professionals about therapy selection for …
Camizestrant Outperforms Fulvestrant in ER+, HER2- Breast Cancer
2 days ago · November 11, 2024. The median progression-free survival was 3.7 months with fulvestrant, 7.2 months with the 75 mg dose of camizestrant and 7.7 months with the 150 mg …
T-DM1 Improves OS vs Trastuzumab in Breast Cancer Patients …
Dec 12, 2023 · Updated results from the KATHERINE trial suggest that ado-trastuzumab emtansine (T-DM1) can improve overall survival (OS) when compared to trastuzumab in …
Antineoplastic Therapy: ASCO-ONS Standards Updated - Cancer …
3 days ago · References: Siegel RD, LeFebvre KB, Temin S, et al. Antineoplastic therapy administration safety standards for adult and pediatric oncology: ASCO-ONS standards. JCO …
Adding Atezolizumab to Chemo Improves Survival in Triple …
Dec 14, 2023 · The combination of atezolizumab and carboplatin improves survival outcomes over carboplatin alone in patients with metastatic triple-negative breast cancer (TNBC), …
Breast Cancer Treatment & Pharmacologic Management
May 17, 2023 · Updated 9/24/2024. Breast cancer is the most common nondermal cancer in women, but it can also occur in men. The Surveillance, Epidemiology, and End Results …
COVID-19 Vaccine Considerations for Patients With Cancer
February 22, 2021. Several medical societies and professional oncology organizations have released guidance on whether patients with cancer should receive the vaccines that protect …
Systemic Therapy for Melanoma: More and More Choices, Newer …
Jun 10, 2024 · The pace of progress in cancer care is brisk and accelerating, nowhere more so than in the treatment of melanoma. Over the past dozen years, at least a dozen new drugs …
Non-Small Cell Lung Cancer Treatment & Pharmacologic …
May 12, 2023 · Reviewed and updated: 4/4/2024 Lung cancer is the second most common cancer in the United States and estimated to account for 12.2% of new cancer cases in 2023. 1 …